Washington Statutes
§ 69.78.020 — Definitions.
Washington § 69.78.020
JurisdictionWashington
Title 69FOOD, DRUGS, COSMETICS, AND POISONS
Ch. 69.78DIVERSITY IN CLINICAL TRIALS
This text of Washington § 69.78.020 (Definitions.) is published on Counsel Stack Legal Research, covering Washington primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Wash. Rev. Code § 69.78.020 (2026).
Text
The definitions in this section apply throughout this chapter unless the context clearly requires otherwise.
(1)"Washington state review board" or "review board" means the Washington state institutional review board, established pursuant to 45 C.F.R. Part 46, which is the designated institutional review board for the department of social and health services, the department of health, the department of labor and industries, and other state agencies.
(2)"Underrepresented community" or "underrepresented demographic group" means a community or demographic group that is more likely to be historically marginalized and less likely to be included in research and clinical trials represented by race, sex, sexual orientation, socioeconomic status, age, and geographic location.
Free access — add to your briefcase to read the full text and ask questions with AI
Legislative History
[2023 c 426 s 2.]
Nearby Sections
15
§ 69.04.001
Statement of purpose.§ 69.04.002
Introductory.§ 69.04.003
"Federal act" defined.§ 69.04.004
"Intrastate commerce."§ 69.04.005
"Sale."§ 69.04.006
"Director."§ 69.04.007
"Person."§ 69.04.008
"Food."§ 69.04.009
"Drugs."§ 69.04.010
"Device."§ 69.04.011
"Cosmetic."§ 69.04.012
"Official compendium."§ 69.04.013
"Label."§ 69.04.014
"Immediate container."§ 69.04.015
"Labeling."Cite This Page — Counsel Stack
Bluebook (online)
Washington § 69.78.020, Counsel Stack Legal Research, https://law.counselstack.com/statute/wa/69.78.020.